Genomics of Drug Sensitivity in Cancer Imatinib
Synonyms Gleevec, STI-571
Targets ABL, KIT, PDGFR
Target pathway RTK signaling
PubCHEM ID 5291
Jsmol
Download molecule 5291
PUBCHEM IUPAC INCHI InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)
Smiles O=C(NC3(=CC(NC2(=NC(C1(=CN=CC=C1))=CC=N2))=C(C)C=C3))C5(=CC=C(CN4(CCN(C)CC4))C=C5)
Cluster number 90
calculated LogS -4,383
Molecular weight 493,613
calculated LogP 3,9383
H-Acceptors 8
H-Donors 2
Ro5 violations 0
Druglikeness 8,6128
DrugScore 0,54592710101005
Mutagenic none
Tumorigenic none
Reproductive Effective none
Irritant none
Fish Toxicity High FHMT
Fish Toxicity2 1,6957
Rat Acute Toxicity 2,6013
Acute Oral Toxicity III
Caco-2 Permeability Caco2+
Caco-2 Permeability2 0,9844
P-glycoprotein Substrate Substrate
P-glycoprotein Inhibitor Inhibitor
P-glycoprotein Inhibitor2 Non-inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,5167
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Substrate
CYP450 3A4 Inhibitor Non-inhibitor
CYP450 2C19 Inhibitor Non-inhibitor
CYP450 2C9 Inhibitor Non-inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Non-inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB+
CYP Inhibitory Promiscuity Low CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -2,849
Information useful only for research purposes.